Bruker Daltonics provides a variety of innovative mass spectrometry systems.
Company Description
Bruker Daltonics provides a variety of innovative mass spectrometry systems. Our powerful, yet easy to implement, products are specifically designed to meet the rapidly growing needs of customers in the academic, pharmaceutical, industrial, and clinical areas.
Consistently and expertly supported, our turnkey system solutions and complete workflows offer integrated instrument and software tools which enhance the productivity and capabilities of any analytical operation.
Bruker Daltonics product lines include platforms representing many types of separation technologies and mass spectrometry including:
Markets Served
Bruker Daltonics' mass spectrometers are a powerful tool for a wide variety of applications with different analytical challenges.
Our analytical systems combine high performance mass spectrometers, software, and accessories to deliver answers for a broad range of areas including:
Facilities
Bruker Daltonics is headquartered in Billerica, Massachusetts with a sales, service, and applications facility in Fremont, California, as well as major facilities in Germany (Bremen and Leipzig) and the United Kingdom. A global network of demonstration, sales, and service sites provides complete worldwide support for all our products and services.
Bruker Daltonics
40 Manning Road
Billerica, MA 01821
TELEPHONE
(978) 663-3660
FAX
(978) 667-5993
WEB SITE
LC–MS/MS Quantification of Plasma Proteins in Elephant Seals to Advance Wildlife Conservation
November 12th 2024Liquid chromatography and tandem mass spectrometry (LC–MS/MS) was used to show that repeated stress can cause delayed but sustained changes in blood plasma proteins associated with water conservation, immune responses, fat metabolism, insulin sensitivity, iron recycling, and hormone transport in elephant seals. Some of these changes may be novel markers of recent and chronic stress exposure in marine mammals.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.